Reaching multidisciplinary consensus on the management of non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer.
Fiche publication
Date publication
janvier 2023
Journal
Lung cancer (Amsterdam, Netherlands)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel, Dr MARTIN Etienne
Tous les auteurs :
Scherpereel A, Martin E, Brouchet L, Corre R, Duruisseaux M, Falcoz PE, Giraud P, Le Péchoux C, Wislez M, Alifano M
Lien Pubmed
Résumé
The optimal management of patients with non-bulky/non-infiltrative stage IIIA N2 non-small cell lung cancer (NSCLC) remains controversial. In this modified Delphi study from France, we aimed to generate agreement through multidisciplinary decision-making on the clinical management of patients with non-bulky/non-infiltrative N2 NSCLC.
Mots clés
Delphi consensus, Multidisciplinary consensus, Multidisciplinary tumour board, N2 disease, Non-bulky/non-infiltrative, Non-small cell lung cancer
Référence
Lung Cancer. 2023 01 18;177:21-28